Evidence map›Paper›PMID 37145189›Full record

ArticleCellular and molecular life sciences : CMLS2023

Microglial P2X4 receptors promote ApoE degradation and contribute to memory deficits in Alzheimer's disease.

Jennifer Hua, Elvira Garcia de Paco, Nathalie Linck, Tangui Maurice, Catherine Desrumaux, Bénédicte Manoury, François Rassendren, Lauriane Ulmann

Open access · hybridAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jennifer HuaIGF, Univ Montpellier, CNRS, INSERM, Montpellier, France.
Elvira Garcia de PacoIGF, Univ Montpellier, CNRS, INSERM, Montpellier, France.
Nathalie LinckIGF, Univ Montpellier, CNRS, INSERM, Montpellier, France.
Tangui MauriceMMDN, Univ Montpellier, EPHE, INSERM, Montpellier, France.
Catherine DesrumauxMMDN, Univ Montpellier, EPHE, INSERM, Montpellier, France.
Bénédicte ManouryInstitut Necker Enfants Malades, INSERM, CNRS, Université de Paris, Paris, France.
François Rassendren *IGF, Univ Montpellier, CNRS, INSERM, Montpellier, France.
Lauriane Ulmann *IGF, Univ Montpellier, CNRS, INSERM, Montpellier, France. lauriane.ulmann@igf.cnrs.fr.ORCID http://orcid.org/0000-0002-2202-6733
Centre National de la Recherche Scientifique · FRInserm · FR

Funding

ICST Labex ANR-11-LABX-0015La fondation NRJ-Institut de France La fondation NRJ-Institut de France
6 · The paper itself

Abstract

Numerous evidences support that microglia contributes to the progression of Alzheimer's disease. P2X4 receptors are ATP-gated channels with high calcium permeability, which are de novo expressed in a subset of reactive microglia associated with various pathological contexts, contributing to microglial functions. P2X4 receptors are mainly localized in lysosomes and trafficking to the plasma membrane is tightly regulated. Here, we investigated the role of P2X4 in the context of Alzheimer's disease (AD). Using proteomics, we identified Apolipoprotein E (ApoE) as a specific P2X4 interacting protein. We found that P2X4 regulates lysosomal cathepsin B (CatB) activity promoting ApoE degradation; P2rX4 deletion results in higher amounts of intracellular and secreted ApoE in both bone-marrow-derived macrophage (BMDM) and microglia from APP

Indexed as

Alzheimer DiseaseAmyloid beta-Protein PrecursorAnimalsApolipoproteins EDisease Models, AnimalHumansMemory DisordersMiceMice, TransgenicMicrogliaPlaque, AmyloidReceptors, Purinergic P2X4Amyloid beta-Protein PrecursorApolipoproteins EReceptors, Purinergic P2X4CathepsinLysosomeProteomicPurinergic signalingSoluble Aß peptide

Identifiers

PMID37145189
PMCPMC10163120
OpenAlexW4372295426

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.